These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
665 related items for PubMed ID: 21860636
1. Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure. Yoon JH, Kim JS, Lee DH, Shim EJ, Lee SY, Min KS, Cho DJ, Lee HR. Korean Circ J; 2011 Jul; 41(7):356-62. PubMed ID: 21860636 [Abstract] [Full Text] [Related]
2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators. JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037 [Abstract] [Full Text] [Related]
3. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism. Wintzer-Wehekind J, Alperi A, Houde C, Côté JM, Asmarats L, Côté M, Rodés-Cabau J. J Am Coll Cardiol; 2019 Jan 29; 73(3):278-287. PubMed ID: 30678757 [Abstract] [Full Text] [Related]
4. Long-term experience and outcomes with transcatheter closure of patent foramen ovale. Inglessis I, Elmariah S, Rengifo-Moreno PA, Margey R, O'Callaghan C, Cruz-Gonzalez I, Baron S, Mehrotra P, Tan TC, Hung J, Demirjian ZN, Buonanno FS, Ning M, Silverman SB, Cubeddu RJ, Pomerantsev E, Schainfeld RM, Dec GW, Palacios IF. JACC Cardiovasc Interv; 2013 Nov 29; 6(11):1176-83. PubMed ID: 24262618 [Abstract] [Full Text] [Related]
5. Long-term follow-up after percutaneous closure of patent foramen ovale with Amplatzer PFO Occluder: a single center experience. Araszkiewicz A, Grygier M, Iwańczyk S, Trojnarska O, Lesiak M, Grajek S. Postepy Kardiol Interwencyjnej; 2016 Nov 29; 12(1):49-54. PubMed ID: 26966449 [Abstract] [Full Text] [Related]
6. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device. Fischer D, Haentjes J, Klein G, Schieffer B, Drexler H, Meyer GP, Schaefer A. J Interv Cardiol; 2011 Feb 29; 24(1):85-91. PubMed ID: 20735710 [Abstract] [Full Text] [Related]
11. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Ntaios G, Papavasileiou V, Makaritsis K, Michel P. Int J Cardiol; 2013 Oct 30; 169(2):101-5. PubMed ID: 24041984 [Abstract] [Full Text] [Related]
16. Percutaneous closure of patent foramen ovale in cryptogenic embolism. Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P, PC Trial Investigators. N Engl J Med; 2013 Mar 21; 368(12):1083-91. PubMed ID: 23514285 [Abstract] [Full Text] [Related]
17. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure. Davies A, Ekmejian A, Collins N, Bhagwandeen R. Heart Lung Circ; 2017 Mar 21; 26(3):246-250. PubMed ID: 27555053 [Abstract] [Full Text] [Related]